Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor of Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01865903
What this trial is testing

Nutritional Problems and Changes in Body Composition in Patients With Non-small Cell Lung Cancer (LEKS)

Who this might be right for
Weight LossCachexia
Oslo University Hospital 17
Large-scale testing (Phase 3)Not Yet RecruitingNCT06102161
What this trial is testing

Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020)

Who this might be right for
Lung CancerWedge ResectionGround-glass Opacity
Fudan University 286
Early research (Phase 1)Ended earlyNCT00955942
What this trial is testing

Flaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation Therapy

Who this might be right for
Lung CancerRadiation Toxicity
Abramson Cancer Center at Penn Medicine 48
Large-scale testing (Phase 3)Study completedNCT00446225
What this trial is testing

Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR

Who this might be right for
Non-Small Cell Lung Cancer
Spanish Lung Cancer Group 174
Large-scale testing (Phase 3)Looking for participantsNCT07472517
What this trial is testing

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

Who this might be right for
Small Cell Lung Cancer (SCLC)Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Boehringer Ingelheim 670
Testing effectiveness (Phase 2)Study completedNCT02659059
What this trial is testing

Nivolumab in Combination With Ipilimumab (Part 1); Nivolumab Plus Ipilimumab in Combination With Chemotherapy (Part 2) as First Line Therapy in Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
Bristol-Myers Squibb 324
Not applicableUnknownNCT05715996
What this trial is testing

Application of Mixed Reality Technique for Percutaneous Lung Nodule Localization: A Prospective, Randomized, Controlled Trial

Who this might be right for
Lung Cancer
Shanghai Chest Hospital 74
Not applicableActive Not RecruitingNCT06383988
What this trial is testing

A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources

Who this might be right for
Stage II Lung CancerStage III Lung CancerStage IV Lung Cancer
Wake Forest University Health Sciences 216
Testing effectiveness (Phase 2)UnknownNCT03349203
What this trial is testing

Icotinib as Neoadjuvant and Adjuvant Therapy in EGFR-mutant Stage IIIB or Oligometastasis Non-small Cell Lung Cancer

Who this might be right for
EGF-R Positive Non-Small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 60
Large-scale testing (Phase 3)UnknownNCT03745261
What this trial is testing

Effect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPD

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Henan University of Traditional Chinese Medicine 240
Testing effectiveness (Phase 2)Study completedNCT01757288
What this trial is testing

Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC

Who this might be right for
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
University of Texas Southwestern Medical Center 98
Large-scale testing (Phase 3)Not Yet RecruitingNCT07822542
What this trial is testing

A Study Evaluating HS-10370 Plus Platinum-based Doublet Chemotherapy With or Without Adebrelimab vs. Tislelizumab Plus Chemotherapy as First-Line Therapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Jiangsu Hansoh Pharmaceutical Co., Ltd. 448
Not applicableLooking for participantsNCT05632913
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Lung Cancer

Who this might be right for
Recurrent Lung CancerLung Cancer
Alpha Tau Medical LTD. 10
Not applicableLooking for participantsNCT07391280
What this trial is testing

Strategy for EArly Recognition of Cancer, COPD & Heart Failure in the Emergency Department

Who this might be right for
CancerCardiovascularRespiratory
NHS Greater Glasgow and Clyde 17,000
Not applicableUnknownNCT00899262
What this trial is testing

Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers

Who this might be right for
Lung CancerTobacco Use Disorder
South West Wales Cancer Institute 300
Not applicableStudy completedNCT05693246
What this trial is testing

Effect of Perioperative Use of Glycopyrrolate on Lung Function in Patients Under General Anesthesia

Who this might be right for
Glycopyrrolate
Zhuan Zhang 52
Not applicableEnrolling By InvitationNCT05212103
What this trial is testing

PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9

Who this might be right for
Acute Myeloid LeukemiaMelanomaNon Small Cell Lung Cancer
Turku University Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT04789486
What this trial is testing

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Who this might be right for
Non-small Cell Lung CancerAdvanced Pancreatic AdenocarcinomaUnresectable Pancreatic Cancer+1 more
Dana-Farber Cancer Institute 100
Large-scale testing (Phase 3)Looking for participantsNCT07481786
What this trial is testing

Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases

Who this might be right for
Lung AdenocarcinomaBrain MetastasesRadiotherapy, Intensity-Modulated+2 more
Sun Yat-sen University 220
Not applicableAvailableNCT06761976
What this trial is testing

Expanded Access to Provide Sevabertinib (BAY 2927088) for the Treatment of Locally Advanced or Metastatic NSCLC With HER2 Mutation

Who this might be right for
Advanced Non-small Cell Lung CancerCancer
Bayer
Next Page